Pasithea Therapeutics CORP. (KTTAW) — 8-K Filings

8-K Filings (18)

• Pasithea Therapeutics Files 8-K on Other Events — Dec 15, 2025 Risk: low
  Pasithea Therapeutics Corp. filed an 8-K on December 15, 2025, reporting an event on December 12, 2025. The filing pertains to "Other Events" and includes detai
• 8-K Filing — Dec 2, 2025
• Pasithea Therapeutics Files 8-K — Nov 25, 2025 Risk: low
  Pasithea Therapeutics Corp. filed an 8-K on November 25, 2025, reporting events that occurred on November 20, 2025. The filing includes information related to R
• Pasithea Therapeutics Files 8-K — Nov 4, 2025 Risk: low
  Pasithea Therapeutics Corp. filed an 8-K on November 4, 2025, reporting on events that occurred on the same date. The filing includes information related to Reg
• Pasithea Therapeutics Corp. Files 8-K on Officer/Director Changes — Oct 27, 2025 Risk: medium
  Pasithea Therapeutics Corp. filed an 8-K on October 27, 2025, reporting events as of October 24, 2025. The filing indicates changes related to the departure of
• Pasithea Therapeutics Files 8-K — Sep 16, 2025 Risk: low
  Pasithea Therapeutics Corp. filed an 8-K on September 16, 2025, reporting on events including Regulation FD disclosures, other events, and financial statements.
• Pasithea Therapeutics Corp. Files 8-K on Corporate Governance Changes — Sep 3, 2025 Risk: medium
  Pasithea Therapeutics Corp. filed an 8-K on September 3, 2025, reporting on the departure of directors, election of new directors, appointment of officers, and
• Pasithea Therapeutics Files 8-K on Shareholder Nominations — Jul 11, 2025 Risk: medium
  Pasithea Therapeutics Corp. filed an 8-K on July 11, 2025, reporting shareholder nominations pursuant to Exchange Act Rule 14a-11. The filing indicates that the
• Pasithea Therapeutics Faces Delisting Notice — Jun 27, 2025 Risk: high
  Pasithea Therapeutics Corp. filed an 8-K on June 27, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard as of June
• Pasithea Therapeutics Files 8-K — Jun 20, 2025 Risk: low
  On June 20, 2025, Pasithea Therapeutics Corp. filed an 8-K report. The filing primarily concerns other events and financial statements/exhibits, with no specifi
• Pasithea Therapeutics Corp. Files 8-K with Material Agreement — May 7, 2025 Risk: medium
  On May 6, 2025, Pasithea Therapeutics Corp. entered into a material definitive agreement. The company also made a Regulation FD disclosure and filed financial s
• Pasithea Therapeutics Changes Auditors — Apr 25, 2025 Risk: medium
  Pasithea Therapeutics Corp. announced on April 23, 2025, a change in its certifying accountant. The company has dismissed Marcum LLP as its independent register
• Pasithea Therapeutics Files 8-K with Material Agreement — Nov 26, 2024 Risk: medium
  On November 26, 2024, Pasithea Therapeutics Corp. filed an 8-K report detailing a material definitive agreement. The filing also includes financial statements a
• Pasithea Therapeutics Files 8-K for Equity Sales — Sep 30, 2024 Risk: medium
  On September 26, 2024, Pasithea Therapeutics Corp. entered into a material definitive agreement related to unregistered sales of equity securities. The company
• Pasithea Therapeutics Files 8-K — Sep 26, 2024 Risk: low
  Pasithea Therapeutics Corp. filed an 8-K on September 26, 2024, to report a Regulation FD Disclosure and Financial Statements and Exhibits. The filing indicates
• Pasithea Therapeutics Files 8-K on Shareholder Vote Matters — Jun 26, 2024 Risk: low
  Pasithea Therapeutics Corp. filed an 8-K on June 26, 2024, to report on matters submitted to a vote of its security holders. The filing does not contain details
• Pasithea Therapeutics Confirms Nasdaq Listing in 8-K Filing — Jan 18, 2024
  Pasithea Therapeutics Corp. (KTTA) filed an 8-K on January 18, 2024, reporting an 'Other Event' that occurred on January 17, 2024. While the filing itself is br
• Pasithea Therapeutics: Material Rights Modification for Stock & Warrants — Jan 2, 2024
  Pasithea Therapeutics Corp. filed an 8-K on January 2, 2024, reporting a material modification to the rights of its security holders, specifically regarding its

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX